Within the AD continuum, YKL-40 levels were significantly higher in patients with AD dementia compared with MCI-AD, with a small effect size (0.34, 95% CI 0.10–0.57, p = 0.0048, Figure 3). The gene discussed is CHI3L1; the disease is Alzheimer disease.